FDA fast-tracks approval for Alzheimer's drughttps://wpnnradio.com/wp-content/themes/movedo/images/empty/thumbnail.jpg150150adminadminhttps://secure.gravatar.com/avatar/790df65a416873c3f0501d984b0b24a2f32bf2af0d1509085b901ade4bbb36e7?s=96&d=mm&r=g
The Food and Drug Administration approved a new Alzheimer’s drug called Leqembi, that has been shown to slow the decline in memory and thinking. The medication costs more than $26,000 per year. source
